CRETELLA, DANIELE
CRETELLA, DANIELE
Dipartimento di Medicina e Chirurgia
Acquired BRAF G469A Mutation as a Resistance Mechanism to First-Line Osimertinib Treatment in NSCLC Cell Lines Harboring an EGFR Exon 19 Deletion
2019-01-01 La Monica, S.; Minari, R.; Cretella, D.; Bonelli, M.; Fumarola, C.; Cavazzoni, A.; Galetti, M.; Digiacomo, G.; Riccardi, F.; Petronini, P. G.; Tiseo, M.; Alfieri, R.
Anti-proliferative effects of copper(II) complexes with hydroxyquinoline-thiosemicarbazone ligands
2017-01-01 Rogolino, Dominga; Cavazzoni, Andrea; Gatti, Anna; Tegoni, Matteo; Pelosi, Giorgio; Verdolino, Vincenzo; Fumarola, Claudia; Cretella, Daniele; Petronini, Pier Giorgio; Carcelli, Mauro
CDK4/6 inhibitors in HER2-positive breast cancer
2017-01-01 Corona, Silvia Paola; Ravelli, Andrea; Cretella, Daniele; Cappelletti, Maria Rosa; Zanotti, Laura; Dester, Martina; Gobbi, Angela; Petronini, Pier Giorgio; Generali, Daniele
CDK4/6 inhibitors overcome resistance to osimertinib in NSCLC cell lines independently from resistance mechanisms
2019-01-01 Cretella, D; La Monica, S; Minari, R; Cavazzoni, A; Galetti, M; Petronini, P. G.; Tiseo, M; Alfieri, R.
Combination of Gefitinib and Pemetrexed Prevents the Acquisition of TKI Resistance in NSCLC Cell Lines Carrying EGFR-Activating Mutation
2016-01-01 LA MONICA, Silvia; Madeddu, Denise; Tiseo, Marcello; Vivo, Valentina; Galetti, Maricla; Cretella, Daniele; Bonelli, Mara; Fumarola, Claudia; Cavazzoni, Andrea; Falco, Angela; Gervasi, Andrea; Lagrasta, Costanza Anna Maria; Naldi, Nadia; Barocelli, Elisabetta; Ardizzoni, Andrea; Quaini, Federico; Petronini, Pier Giorgio; Alfieri, Roberta
Combined Inhibition of CDK4/6 and PI3K/AKT/mTOR Pathways Induces a Synergistic Anti-Tumor Effect in Malignant Pleural Mesothelioma Cells.
2017-01-01 Bonelli, Mara; Digiacomo, Graziana; Fumarola, Claudia; Alfieri, Roberta; Quaini, Federico; Falco, Angela; Madeddu, Denise; LA MONICA, Silvia; Cretella, Daniele; Ravelli, Andrea; Ulivi, P; Tebaldi, M; Calistri, D; Delmonte, A; Ampollini, Luca; Carbognani, Paolo; Tiseo, Marcello; Cavazzoni, Andrea; Petronini, Pier Giorgio
Combined use of anti-ErbB monoclonal antibodies and erlotinib enhances antibody-dependent cellular cytotoxicity of wild-type erlotinib-sensitive NSCLC cell lines
2012-01-01 Cavazzoni, A.; Alfieri, R.; Cretella, D.; Saccani, F.; Ampollini, L.; Galetti, M.; Quaini, F.; Graiani., G.; Madeddu, D.; Mozzoni, P.; Galvani, E.; La Monica, S.; Bonelli, M.; Fumarola, C.; Mutti, A.; Carbognani, P.; Tiseo, M.; Barocelli, E.; Petronini, P. G.; Ardizzoni, A.
Drug-induced cellular death dynamics monitored by a highly sensitive organic electrochemical system
2015-01-01 Romeo, Agostino; Tarabella, G.; D'Angelo, P.; Caffarra, Cristina; Cretella, Daniele; Alfieri, Roberta; Petronini, Pier Giorgio; Iannotta, S.
Dual inhibition of CDK4/6 and PI3K/AKT/mTOR signaling impairs energy metabolism in MPM cancer cells
2020-01-01 Bonelli, M.; Terenziani, R.; Zoppi, S.; Fumarola, C.; La Monica, S.; Cretella, D.; Alfieri, R.; Cavazzoni, A.; Digiacomo, G.; Galetti, M.; Petronini, P. G.
Effect of ABCG2/BCRP Expression on Efflux and Uptake of Gefitinib in NSCLC Cell Lines
2015-01-01 Galetti, Maricla; Petronini, Pier Giorgio; Fumarola, Claudia; Cretella, Daniele; LA MONICA, Silvia; Bonelli, Mara; Cavazzoni, Andrea; Saccani, Francesca; Caffarra, Cristina; Andreoli, Roberta; Mutti, Antonio; Tiseo, Marcello; Ardizzoni, Andrea; Alfieri, Roberta
Effect of specific PI3K/mTOR inhibitors in squamous lung cancer cells carrying PI3K alterations
2014-01-01 Bonelli, M; Cavazzoni, A; La Monica, S; Galetti, M; Caffarra, C; Cretella, D; Saccani, F; Fumarola, C; Alfieri, R; Petronini, Pg.
Effects of FGFR1 inhibition on survival, proliferation, and energy metabolism in Non Small Cell Lung Cancer (NSCLC) cell lines
2014-01-01 Fumarola, C; Caffarra, C; Cretella, D; Galetti, M; Bonelli, M; Cavazzoni, A; La Monica, S; Saccani, F; Alfieri, R; Petronini, Pg.
Efficacy of the cdk4/6 dual inhibitor abemaciclib in egfr-mutated nsclc cell lines with different resistance mechanisms to osimertinib
2021-01-01 LA Monica, S.; Fumarola, C.; Cretella, D.; Bonelli, M.; Minari, R.; Cavazzoni, A.; Digiacomo, G.; Galetti, M.; Volta, F.; Mancini, M.; Petronini, P. G.; Tiseo, M.; Alfieri, R.
Enhanced efficacy of AKT and FAK kinase combined inhibition in squamous cell lung carcinomas with stable reduction in PTEN
2017-01-01 Cavazzoni, Andrea; La Monica, Silvia; Alfieri, Roberta; Ravelli, Andrea; Steen, Nele Van Der; Sciarrillo, Rocco; Madeddu, Denise; Lagrasta, Costanza Anna Maria; Quaini, Federico; Bonelli, Mara; Fumarola, Claudia; Cretella, Daniele; Digiacomo, Graziana; Tiseo, Marcello; Peters, Godefridus J.; Ardizzoni, Andrea; Petronini, Pier Giorgio; and Elisa, Giovannetti
Enhancement of the anti-tumor activity of FGFR1 inhibition in squamous cell lung cancer by targeting downstream signaling involved in glucose metabolism.
2017-01-01 Fumarola, Claudia; Cretella, Daniele; LA MONICA, Silvia; Bonelli, Mara; Alfieri, Roberta; Caffarra, Cristina; Quaini, Federico; Madeddu, Denise; Falco, Angela; Cavazzoni, Andrea; Digiacomo, Graziana; Mazzaschi, Giulia; Vivo, Valentina; Barocelli, Elisabetta; Tiseo, Marcello; Petronini, Pier Giorgio; Ardizzoni, Andrea
Erlotinib enhances antibody-dependent cellular cytotoxicity of wil-type erlotinib-sensitive NSCLC cell lines
2012-01-01 Cretella, D; Cavazzoni, A; Saccani, F; Alfieri, R; Petronini, Pg.
Expanding the Arsenal of FGFR Inhibitors: A Novel Chloroacetamide Derivative as a New Irreversible Agent With Anti-proliferative Activity Against FGFR1-Amplified Lung Cancer Cell Lines.
2019-01-01 Fumarola, C; Bozza, N; Castelli, R; Ferlenghi, F; Marseglia, Giuseppe; Lodola, A; Bonelli, M; La Monica, S; Cretella, D; Alfieri, R; Minari, R; Galetti, M; Tiseo, M; Ardizzoni, A; Mor, M; Petronini, Pg.
Inhibition of PI3K Pathway Reduces Invasiveness and Epithelial-to-Mesenchymal Transition in Squamous Lung Cancer Cell Lines Harboring PIK3CA Gene Alterations.
2015-01-01 Bonelli, Mara; Cavazzoni, Andrea; Saccani, Francesca; Alfieri, Roberta; Quaini, Federico; LA MONICA, Silvia; Galetti, Maricla; Cretella, Daniele; Caffarra, Cristina; Madeddu, Denise; Frati, Caterina; Lagrasta, Costanza Anna Maria; Falco, Angela; Rossetti, Pietro; Fumarola, Claudia; Tiseo, Marcello; Petronini, Pier Giorgio; Ardizzoni, A.
MESENCHYMAL STROMAL CELLS ISOLATED FROM DEFINED NSCLC CONTEXTURES REPRODUCE THE IMMUNE SIGNATURE OF THE PARENTAL MICROENVIRONMENT
2018-01-01 Madeddu, Denise; Falco, A.; Cretella, D.; La Monica, S.; Lorusso, B.; Frati, C.; Lagrasta, C.; Cavalli, S.; Alfieri, R.; Mazzaschi, G.; Armani, G.; Gnetti, L.; Bonomini, S.; Bocchialini, G.; Rusca, M.; Quaini, F.; Ampollini, L.
Metronomic chemotherapy for advanced breast cancer patients in the real world practice: Final results of the VICTOR-6 study
2019-01-01 Cazzaniga, M. E.; Pinotti, G.; Montagna, E.; Amoroso, D.; Berardi, R.; Butera, A.; Cagossi, K.; Cavanna, L.; Ciccarese, M.; Cinieri, S.; Cretella, E.; De Conciliis, E.; Febbraro, A.; Ferrau, F.; Ferzi, A.; Fiorentini, G.; Fontana, A.; Gambaro, A. R.; Garrone, O.; Gebbia, V.; Generali, D.; Gianni, L.; Giovanardi, F.; Grassadonia, A.; Leonardi, V.; Marchetti, P.; Melegari, E.; Musolino, A.; Nicolini, M.; Putzu, C.; Riccardi, F.; Santini, D.; Saracchini, S.; Sarobba, M. G.; Schintu, M. G.; Scognamiglio, G.; Spadaro, P.; Taverniti, C.; Toniolo, D.; Tralongo, P.; Turletti, A.; Valenza, R.; Valerio, M. R.; Vici, P.; Clivio, L.; Torri, V.; Cicchiello, F.; Riva, F.; Vallini, I.; Mazza, M.; Bonfadini, C.; Bordin, E.; Canicatti, M.; Cappuccio, F.; Collova, E.; De Angelis, C.; Desorte, R.; Donati, S.; Drudi, G.; Galanti, D.; Mocerino, C.; Orlando, L.; Pellegrino, B.; Pizzuti, L.; Ridolfi, C.; Rocca, A.; Sarti, D.; Spagnoletti, I.; Tinari, N.; Vandone, A.; Vizzini, L.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Acquired BRAF G469A Mutation as a Resistance Mechanism to First-Line Osimertinib Treatment in NSCLC Cell Lines Harboring an EGFR Exon 19 Deletion | 1-gen-2019 | La Monica, S.; Minari, R.; Cretella, D.; Bonelli, M.; Fumarola, C.; Cavazzoni, A.; Galetti, M.; Digiacomo, G.; Riccardi, F.; Petronini, P. G.; Tiseo, M.; Alfieri, R. | |
| Anti-proliferative effects of copper(II) complexes with hydroxyquinoline-thiosemicarbazone ligands | 1-gen-2017 | Rogolino, Dominga; Cavazzoni, Andrea; Gatti, Anna; Tegoni, Matteo; Pelosi, Giorgio; Verdolino, Vincenzo; Fumarola, Claudia; Cretella, Daniele; Petronini, Pier Giorgio; Carcelli, Mauro | |
| CDK4/6 inhibitors in HER2-positive breast cancer | 1-gen-2017 | Corona, Silvia Paola; Ravelli, Andrea; Cretella, Daniele; Cappelletti, Maria Rosa; Zanotti, Laura; Dester, Martina; Gobbi, Angela; Petronini, Pier Giorgio; Generali, Daniele | |
| CDK4/6 inhibitors overcome resistance to osimertinib in NSCLC cell lines independently from resistance mechanisms | 1-gen-2019 | Cretella, D; La Monica, S; Minari, R; Cavazzoni, A; Galetti, M; Petronini, P. G.; Tiseo, M; Alfieri, R. | |
| Combination of Gefitinib and Pemetrexed Prevents the Acquisition of TKI Resistance in NSCLC Cell Lines Carrying EGFR-Activating Mutation | 1-gen-2016 | LA MONICA, Silvia; Madeddu, Denise; Tiseo, Marcello; Vivo, Valentina; Galetti, Maricla; Cretella, Daniele; Bonelli, Mara; Fumarola, Claudia; Cavazzoni, Andrea; Falco, Angela; Gervasi, Andrea; Lagrasta, Costanza Anna Maria; Naldi, Nadia; Barocelli, Elisabetta; Ardizzoni, Andrea; Quaini, Federico; Petronini, Pier Giorgio; Alfieri, Roberta | |
| Combined Inhibition of CDK4/6 and PI3K/AKT/mTOR Pathways Induces a Synergistic Anti-Tumor Effect in Malignant Pleural Mesothelioma Cells. | 1-gen-2017 | Bonelli, Mara; Digiacomo, Graziana; Fumarola, Claudia; Alfieri, Roberta; Quaini, Federico; Falco, Angela; Madeddu, Denise; LA MONICA, Silvia; Cretella, Daniele; Ravelli, Andrea; Ulivi, P; Tebaldi, M; Calistri, D; Delmonte, A; Ampollini, Luca; Carbognani, Paolo; Tiseo, Marcello; Cavazzoni, Andrea; Petronini, Pier Giorgio | |
| Combined use of anti-ErbB monoclonal antibodies and erlotinib enhances antibody-dependent cellular cytotoxicity of wild-type erlotinib-sensitive NSCLC cell lines | 1-gen-2012 | Cavazzoni, A.; Alfieri, R.; Cretella, D.; Saccani, F.; Ampollini, L.; Galetti, M.; Quaini, F.; Graiani., G.; Madeddu, D.; Mozzoni, P.; Galvani, E.; La Monica, S.; Bonelli, M.; Fumarola, C.; Mutti, A.; Carbognani, P.; Tiseo, M.; Barocelli, E.; Petronini, P. G.; Ardizzoni, A. | |
| Drug-induced cellular death dynamics monitored by a highly sensitive organic electrochemical system | 1-gen-2015 | Romeo, Agostino; Tarabella, G.; D'Angelo, P.; Caffarra, Cristina; Cretella, Daniele; Alfieri, Roberta; Petronini, Pier Giorgio; Iannotta, S. | |
| Dual inhibition of CDK4/6 and PI3K/AKT/mTOR signaling impairs energy metabolism in MPM cancer cells | 1-gen-2020 | Bonelli, M.; Terenziani, R.; Zoppi, S.; Fumarola, C.; La Monica, S.; Cretella, D.; Alfieri, R.; Cavazzoni, A.; Digiacomo, G.; Galetti, M.; Petronini, P. G. | |
| Effect of ABCG2/BCRP Expression on Efflux and Uptake of Gefitinib in NSCLC Cell Lines | 1-gen-2015 | Galetti, Maricla; Petronini, Pier Giorgio; Fumarola, Claudia; Cretella, Daniele; LA MONICA, Silvia; Bonelli, Mara; Cavazzoni, Andrea; Saccani, Francesca; Caffarra, Cristina; Andreoli, Roberta; Mutti, Antonio; Tiseo, Marcello; Ardizzoni, Andrea; Alfieri, Roberta | |
| Effect of specific PI3K/mTOR inhibitors in squamous lung cancer cells carrying PI3K alterations | 1-gen-2014 | Bonelli, M; Cavazzoni, A; La Monica, S; Galetti, M; Caffarra, C; Cretella, D; Saccani, F; Fumarola, C; Alfieri, R; Petronini, Pg. | |
| Effects of FGFR1 inhibition on survival, proliferation, and energy metabolism in Non Small Cell Lung Cancer (NSCLC) cell lines | 1-gen-2014 | Fumarola, C; Caffarra, C; Cretella, D; Galetti, M; Bonelli, M; Cavazzoni, A; La Monica, S; Saccani, F; Alfieri, R; Petronini, Pg. | |
| Efficacy of the cdk4/6 dual inhibitor abemaciclib in egfr-mutated nsclc cell lines with different resistance mechanisms to osimertinib | 1-gen-2021 | LA Monica, S.; Fumarola, C.; Cretella, D.; Bonelli, M.; Minari, R.; Cavazzoni, A.; Digiacomo, G.; Galetti, M.; Volta, F.; Mancini, M.; Petronini, P. G.; Tiseo, M.; Alfieri, R. | |
| Enhanced efficacy of AKT and FAK kinase combined inhibition in squamous cell lung carcinomas with stable reduction in PTEN | 1-gen-2017 | Cavazzoni, Andrea; La Monica, Silvia; Alfieri, Roberta; Ravelli, Andrea; Steen, Nele Van Der; Sciarrillo, Rocco; Madeddu, Denise; Lagrasta, Costanza Anna Maria; Quaini, Federico; Bonelli, Mara; Fumarola, Claudia; Cretella, Daniele; Digiacomo, Graziana; Tiseo, Marcello; Peters, Godefridus J.; Ardizzoni, Andrea; Petronini, Pier Giorgio; and Elisa, Giovannetti | |
| Enhancement of the anti-tumor activity of FGFR1 inhibition in squamous cell lung cancer by targeting downstream signaling involved in glucose metabolism. | 1-gen-2017 | Fumarola, Claudia; Cretella, Daniele; LA MONICA, Silvia; Bonelli, Mara; Alfieri, Roberta; Caffarra, Cristina; Quaini, Federico; Madeddu, Denise; Falco, Angela; Cavazzoni, Andrea; Digiacomo, Graziana; Mazzaschi, Giulia; Vivo, Valentina; Barocelli, Elisabetta; Tiseo, Marcello; Petronini, Pier Giorgio; Ardizzoni, Andrea | |
| Erlotinib enhances antibody-dependent cellular cytotoxicity of wil-type erlotinib-sensitive NSCLC cell lines | 1-gen-2012 | Cretella, D; Cavazzoni, A; Saccani, F; Alfieri, R; Petronini, Pg. | |
| Expanding the Arsenal of FGFR Inhibitors: A Novel Chloroacetamide Derivative as a New Irreversible Agent With Anti-proliferative Activity Against FGFR1-Amplified Lung Cancer Cell Lines. | 1-gen-2019 | Fumarola, C; Bozza, N; Castelli, R; Ferlenghi, F; Marseglia, Giuseppe; Lodola, A; Bonelli, M; La Monica, S; Cretella, D; Alfieri, R; Minari, R; Galetti, M; Tiseo, M; Ardizzoni, A; Mor, M; Petronini, Pg. | |
| Inhibition of PI3K Pathway Reduces Invasiveness and Epithelial-to-Mesenchymal Transition in Squamous Lung Cancer Cell Lines Harboring PIK3CA Gene Alterations. | 1-gen-2015 | Bonelli, Mara; Cavazzoni, Andrea; Saccani, Francesca; Alfieri, Roberta; Quaini, Federico; LA MONICA, Silvia; Galetti, Maricla; Cretella, Daniele; Caffarra, Cristina; Madeddu, Denise; Frati, Caterina; Lagrasta, Costanza Anna Maria; Falco, Angela; Rossetti, Pietro; Fumarola, Claudia; Tiseo, Marcello; Petronini, Pier Giorgio; Ardizzoni, A. | |
| MESENCHYMAL STROMAL CELLS ISOLATED FROM DEFINED NSCLC CONTEXTURES REPRODUCE THE IMMUNE SIGNATURE OF THE PARENTAL MICROENVIRONMENT | 1-gen-2018 | Madeddu, Denise; Falco, A.; Cretella, D.; La Monica, S.; Lorusso, B.; Frati, C.; Lagrasta, C.; Cavalli, S.; Alfieri, R.; Mazzaschi, G.; Armani, G.; Gnetti, L.; Bonomini, S.; Bocchialini, G.; Rusca, M.; Quaini, F.; Ampollini, L. | |
| Metronomic chemotherapy for advanced breast cancer patients in the real world practice: Final results of the VICTOR-6 study | 1-gen-2019 | Cazzaniga, M. E.; Pinotti, G.; Montagna, E.; Amoroso, D.; Berardi, R.; Butera, A.; Cagossi, K.; Cavanna, L.; Ciccarese, M.; Cinieri, S.; Cretella, E.; De Conciliis, E.; Febbraro, A.; Ferrau, F.; Ferzi, A.; Fiorentini, G.; Fontana, A.; Gambaro, A. R.; Garrone, O.; Gebbia, V.; Generali, D.; Gianni, L.; Giovanardi, F.; Grassadonia, A.; Leonardi, V.; Marchetti, P.; Melegari, E.; Musolino, A.; Nicolini, M.; Putzu, C.; Riccardi, F.; Santini, D.; Saracchini, S.; Sarobba, M. G.; Schintu, M. G.; Scognamiglio, G.; Spadaro, P.; Taverniti, C.; Toniolo, D.; Tralongo, P.; Turletti, A.; Valenza, R.; Valerio, M. R.; Vici, P.; Clivio, L.; Torri, V.; Cicchiello, F.; Riva, F.; Vallini, I.; Mazza, M.; Bonfadini, C.; Bordin, E.; Canicatti, M.; Cappuccio, F.; Collova, E.; De Angelis, C.; Desorte, R.; Donati, S.; Drudi, G.; Galanti, D.; Mocerino, C.; Orlando, L.; Pellegrino, B.; Pizzuti, L.; Ridolfi, C.; Rocca, A.; Sarti, D.; Spagnoletti, I.; Tinari, N.; Vandone, A.; Vizzini, L. |